Technology News and Research

RSS

Kensey Nash announces strategic agreement with Arthrex for ECM technology

Kensey Nash Corporation, a regenerative medicine company, and Arthrex, Inc., a worldwide leader in sports medicine product development and educational services for orthopaedic surgeons, today announced a strategic agreement regarding products developed from Kensey Nash's unique extracellular matrix technology.

24 Jun 2010

Amorfix Life Sciences, QED Bioscience sign agreement to develop monoclonal antibodies

Amorfix Life Sciences and QED Bioscience announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Under the agreement, QED will generate monoclonal antibodies against several disease specific epitopes on misfolded CD38 protein. The DSE's were identified by Amorfix using their proprietary ProMIS computational platform discovery technology.

24 Jun 2010

USPTO confirms validity of DUSA's key Levulan PDT patent

DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office (USPTO) has completed its re-examination of US Patent No. 5,079,262, "Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid."

24 Jun 2010

ABL to host CRP-Santé COMET subtyping tool within TherapyEdge servers

The licensing and distribution agreement allows ABL to directly host COMET (COntext-based Modeling for Expeditious Typing) subtyping tool developed at CRP-Santé within the TherapyEdge servers; it will mainly interact with the ViroScore Suite system to characterize HIV-1 virus subtypes.

24 Jun 2010

Medica, HealthInsight partner to deliver value-based benefit program to commercial customers

Today, Medica, a leading health care insurance provider headquartered in Minneapolis, and HealthInsight, provider of the leading value-based healthcare incentive platform, announced that they have partnered to deliver a next generation value-based benefit program to Medica's commercial customers.

24 Jun 2010

IDEV enters exclusive distribution agreement with TriReme for GliderXtreme PTA balloon catheter

IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced that it has entered into an exclusive distribution agreement covering the U.S. and Germany for TriReme Medical, Inc.'s (TriReme) GliderXtreme™ PTA balloon catheter, an advanced product with specific features for the expanding Peripheral Arterial Disease (PAD) market.

24 Jun 2010

AGA refused permission to appeal UK Supreme Court for Figulla ASD and PFO occluder patent infringement

In 2009 the Patents Court of the High Court, Chancery Division, decided that Occlutech's range of Figulla ASD and PFO occluders do not infringe the U.K. part of European Patent 0 808 138. AGA Medical decided to appeal against this decision. The U.K. Court of Appeal (civil division) in London announced its decision confirming that said Figulla ASD and PFO occluders do not infringe said patent.

24 Jun 2010

Cancer Research UK launches new cutting-edge research centre at Imperial

A new cutting-edge cancer centre dedicated to robotic surgery, cancer imaging and drug discovery is launched today, putting London at the forefront of cancer research.

24 Jun 2010

Group of tests may help predict falls in people with Parkinson's disease: Study

A group of tests may help predict which people with Parkinson's disease are more likely to fall, according to a study published in the June 23, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology.

24 Jun 2010

nContact reports results of physician-initiated Convergent Procedure study of AF

nContact Surgical, Inc. reports with interest today the results of a physician-initiated study of the Convergent Procedure that, for the first time, measured the progress of persistent atrial fibrillation (AF) patients at one-year and six-month intervals. Results of the study, which were presented at the 2010 International Society of Minimally Invasive Cardiac Surgeons meeting in Berlin, Germany, indicated that after one year 80% of patients were in sinus rhythm and off anti-arrhythmic medication as a result of the closed chest, multi-disciplinary AF procedure.

24 Jun 2010

Alnylam presents data on novel delivery lipids at IBC 6th Annual Cell Line Development and Engineering conference

Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the IBC 6th Annual Cell Line Development and Engineering conference held in San Francisco, California from June 21 - 24, 2010.

24 Jun 2010

MEDSEEK CEO speaks in a series of eHealth podcasts posted on Healthcare Technology Online

MEDSEEK, the healthcare industry industry's only provider of the eHealth ecoSystemTM, today announced that CEO Peter Kuhn is the guest speaker in a series of eHealth podcasts posted on Healthcare Technology Online, an Internet resource for healthcare technology news.

24 Jun 2010

Scientists describe development of special sensor that uses maglev for analyzing food, beverages

Scientists are reporting development of a new use for magnetic levitation, or "maglev," the futuristic technology best known for enabling high-speed passenger trains to float above the tracks. In ACS' bi-weekly Journal of Agricultural and Food Chemistry, they describe putting maglev to use in an inexpensive sensor for analyzing food, water, and other beverages.

24 Jun 2010

RF Technologies completes installation of Safe Place Infant and Pediatric Security Solution for Baptist Memorial

RF Technologies®, a leading provider of radio frequency identification monitoring systems and healthcare security solutions, announces it has completed installation of its Safe Place® Infant and Pediatric Security Solution for Baptist Memorial Health Care. The health care system, serving locations throughout the Mid-South, delivers approximately 10,000 babies a year at eight affiliate hospitals that provide obstetric care.

24 Jun 2010

Telefonica Mexico, Myriad Group nominated for 'Service: Social Use' at 2010 Global Messaging Awards

Telefonica Mexico and Myriad Group AG, in partnership with the Mexican Federal Ministry of Health and researchers at the Harvard School of Public Health, today announced that their combined effort in conducting a H1N1 flu survey via mobile phones was named a finalist for 'Messaging Application or Service: Social Use' at the 2010 Global Messaging Awards.

24 Jun 2010

USPTO rules against claims in LifeWatch '878 patent

Medicomp, Inc. confirmed that it has received an initial ruling by the United States Patent and Trademark Office (USPTO) to reject all claims in regards to LifeWatch patent 7,542,878 (the '878 patent).

24 Jun 2010

NIH to invest $25M over five years for international collaboration on genetic research in Africa

The NIH on Tuesday announced a partnership with Wellcome Trust and the African Society for Human Genetics that will enable African researchers to "use the latest genetic and clinical technology to study common health problems, such as cardiovascular disease, cancer and other diseases," VOA News reports (DeCapua, 6/22).

24 Jun 2010

Debiotech, STMicroelectronics to showcase novel insulin "Jewel Pump" at ADA Congress

Debiotech and STMicroelectronics today announced that they will publicly showcase their novel insulin "Jewel Pump" at the Debiotech stand at the American Diabetes Association 70th Scientific Sessions (June 25-29) in Orlando, Florida.

24 Jun 2010

UK court finds Smith & Nephew's Renasys EZ and Go products infringe KCI patents

Kinetic Concepts, Inc. today announced that the High Court of Justice Chancery Division, Patents Court in the United Kingdom has found that Smith & Nephew plc's Renasys EZ and Go products infringe two KCI patents relating to negative pressure wound therapy.

24 Jun 2010

Miller-McCune examines debate over redistribution of some foreign aid funds from HIV/AIDS to other diseases

Through the lens of health conditions faced by people in Mbarara, Uganda, Miller-McCune examines the debate over redistributing some foreign aid funds from HIV/AIDS to fight other diseases.

24 Jun 2010

Technology News and Research

Kensey Nash announces strategic agreement with Arthrex for ECM technology

Amorfix Life Sciences, QED Bioscience sign agreement to develop monoclonal antibodies

USPTO confirms validity of DUSA's key Levulan PDT patent

ABL to host CRP-Santé COMET subtyping tool within TherapyEdge servers

Medica, HealthInsight partner to deliver value-based benefit program to commercial customers

IDEV enters exclusive distribution agreement with TriReme for GliderXtreme PTA balloon catheter

AGA refused permission to appeal UK Supreme Court for Figulla ASD and PFO occluder patent infringement

Cancer Research UK launches new cutting-edge research centre at Imperial

Group of tests may help predict falls in people with Parkinson's disease: Study

nContact reports results of physician-initiated Convergent Procedure study of AF

Alnylam presents data on novel delivery lipids at IBC 6th Annual Cell Line Development and Engineering conference

MEDSEEK CEO speaks in a series of eHealth podcasts posted on Healthcare Technology Online

Scientists describe development of special sensor that uses maglev for analyzing food, beverages

RF Technologies completes installation of Safe Place Infant and Pediatric Security Solution for Baptist Memorial

Telefonica Mexico, Myriad Group nominated for 'Service: Social Use' at 2010 Global Messaging Awards

USPTO rules against claims in LifeWatch '878 patent

NIH to invest $25M over five years for international collaboration on genetic research in Africa

Debiotech, STMicroelectronics to showcase novel insulin "Jewel Pump" at ADA Congress

UK court finds Smith & Nephew's Renasys EZ and Go products infringe KCI patents

Miller-McCune examines debate over redistribution of some foreign aid funds from HIV/AIDS to other diseases

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News